Certain imidazoquinoxalinols; a new class of GABA brain receptor ligands
AssigneeNeurogen Corporation
InventorsPamela Albaugh, Alan J. Hutchison
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeurogen Corporation
InventorsPamela Albaugh, Alan J. Hutchison
Estimating the term…
The invention encompasses compounds of the formula: ##STR1## and the pharmaceutically acceptable non-toxic salts thereof wherein: X and Y are hydrogen, halogen, hydroxy or amino with the proviso that at least X or Y is hydroxy; and R.sub.1 -R.sub.4 are variables representing various organic and inorganic substituents; and W represents phenyl, 2- or 3-thienyl, or 2-, 3-, or 4-pyridyl; or phenyl, 2- or 3-thienyl, or 2-, 3-, or 4-pyridyl, each of which is mono or disubstituted with various organic or inorganic substituents. These compounds or prodrugs thereof are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs thereof and are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory.
A compound of the formula:
A compound of the formula:
A compound of the formula:
Dependencies are inferred from the claim text.